| Net loss | -11.46M |
| Depreciation | 1.83M |
| Stock-based compensation expense | 6.03M |
| Amortization of purchased intangible assets | 1.87M |
| Provision for doubtful accounts | 0 |
| Other | -31K |
| Accounts receivable | -676K |
| Prepaid expenses and other current assets | -18K |
| Other assets | -323K |
| Accounts payable and accrued liabilities | -546K |
| Accrued compensation | -690K |
| Deferred revenue | 8.79M |
| Net cash provided by operating activities | 4.77M |
| Purchases of property, equipment and leasehold improvements | -1.67M |
| Purchases of marketable securities | -25.73M |
| Maturities of marketable securities | 32.88M |
| Business acquisitions, net of cash acquired | -8.69M |
| Net cash used in investing activities | -3.21M |
| Proceeds from issuance of common stock | 2.68M |
| Payment of employee withholding tax in lieu of issuing common stock | 0 |
| Net cash provided by (used in) financing activities | 2.68M |
| Effect of exchange rate changes on cash and cash equivalents | -32K |
| Net increase (decrease) in cash and cash equivalents | 4.21M |
| Cash and cash equivalents at beginning of period | 26.58M |
| Cash and cash equivalents at end of period | 30.79M |